The European Commission said on Tuesday, April 24, it had fined French telecoms group Altice €125 million (US$153 million) for closing its 2015 takeover of PT Portugal before it had gained regulatory approval.
The European antitrust enforcer said such gun jumping practices undermine its system for scrutinizing mergers. The sanction does not affect its approval of the deal.
The bloc’s rules require that companies do not implement a takeover before they receive approval, to ensure the authorities can correctly assess how the proposed deal will change competition and also to prevent “potentially irreparable” harm to the relevant markets. Margrethe Vestager, EU competition commissioner, said:
“Companies that jump the gun and implement mergers before notification or clearance undermine the effectiveness of our merger control system. This is the system that protects European consumers from any merger that would lead to higher prices or reduced choice. The fine imposed by the commission on Altice today reflects the seriousness of the infringement and should deter other firms from breaking EU merger control rules.”
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas